generation,stage,candidate_idx,risk_aversion,herd_behavior,profit_driven,ticker,company,id,quarter,date,permno,holding_t,y_true,pred,abs_error,reward,valid,best_k,profile_strength_mode,x_risk_mean,x_herd_mean,x_profit_mean,overall_mean,raw_output,reason,answer_body
90,population,0,0.45999954000046006,0.28999971000029,0.24999975000025002,ABT,ABBOTT LABORATORIES,694,NA,2017-04-01 00:00:00,20482,27641.646308,0.1045726744661349,-0.04,0.1445726744661349,-0.1445726744661349,True,1,type_mean,0.0082565895035254,0.0069532062192367,0.2194993243101532,0.0782363733443051,"
<think>Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.4418), the stock appears fundamentally strong but with elevated systematic risk. The fund's current holding is substantial relative to AUM, and the stock's S&P 500 weight is modest, suggesting the position may be overweight compared to benchmark. Considering the high beta and the fund's medium turnover constraint, a reduction in holding to align closer to the benchmark weight or manage risk exposure is likely, leading to a negative normalized log change.</think>
<answer>
{""holding_log_delta"": -0.04}
</answer>","Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.4418), the stock appears fundamentally strong but with elevated systematic risk. The fund's current holding is substantial relative to AUM, and the stock's S&P 500 weight is modest, suggesting the position may be overweight compared to benchmark. Considering the high beta and the fund's medium turnover constraint, a reduction in holding to align closer to the benchmark weight or manage risk exposure is likely, leading to a negative normalized log change.","{""holding_log_delta"": -0.04}"
90,population,1,0.43999956000044005,0.27999972000028006,0.27999972000028006,ABT,ABBOTT LABORATORIES,694,NA,2017-04-01 00:00:00,20482,27641.646308,0.1045726744661349,-0.02,0.1245726744661349,-0.1245726744661349,True,1,type_mean,0.0082565895035254,0.0069532062192367,0.2194993243101532,0.0782363733443051,"
<think>Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.442) indicating higher systematic risk, the stock presents a mix of attractive fundamentals and elevated volatility. The fund's current holding is substantial relative to AUM, and the stock's S&P 500 weight suggests it is a significant benchmark component. Considering the high beta and the fund's existing large position, a modest increase in holding might be expected to align with the benchmark while managing concentration risk, though the elevated volatility could temper the magnitude of any adjustment.</think>
<answer>
{""holding_log_delta"": -0.02}
</answer>","Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.442) indicating higher systematic risk, the stock presents a mix of attractive fundamentals and elevated volatility. The fund's current holding is substantial relative to AUM, and the stock's S&P 500 weight suggests it is a significant benchmark component. Considering the high beta and the fund's existing large position, a modest increase in holding might be expected to align with the benchmark while managing concentration risk, though the elevated volatility could temper the magnitude of any adjustment.","{""holding_log_delta"": -0.02}"
90,population,2,0.5119994880005121,0.24999975000025002,0.237999762000238,ABT,ABBOTT LABORATORIES,694,NA,2017-04-01 00:00:00,20482,27641.646308,0.1045726744661349,-0.06,0.16457267446613488,-0.16457267446613488,True,1,type_mean,0.0082565895035254,0.0069532062192367,0.2194993243101532,0.0782363733443051,"
<think>Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.4418), the stock appears fundamentally strong but with elevated systematic risk. The fund's current holding is substantial relative to AUM, and the stock's S&P 500 weight is modest, suggesting the position may be overweight compared to benchmark. Considering the high beta and the fund's medium turnover constraint, a reduction in holding might be expected to align closer to the benchmark while managing risk exposure.</think>
<answer>
{""holding_log_delta"": -0.06}
</answer>","Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.4418), the stock appears fundamentally strong but with elevated systematic risk. The fund's current holding is substantial relative to AUM, and the stock's S&P 500 weight is modest, suggesting the position may be overweight compared to benchmark. Considering the high beta and the fund's medium turnover constraint, a reduction in holding might be expected to align closer to the benchmark while managing risk exposure.","{""holding_log_delta"": -0.06}"
90,population,3,0.5088423873511602,0.2227346451524601,0.26842196749636954,ABT,ABBOTT LABORATORIES,694,NA,2017-04-01 00:00:00,20482,27641.646308,0.1045726744661349,-0.04,0.1445726744661349,-0.1445726744661349,True,1,type_mean,0.0082565895035254,0.0069532062192367,0.2194993243101532,0.0782363733443051,"
<think>Given the firm's high beta (1.44) and significant market volatility (prev quarter stock_vol_q_prev = 0.1276), the stock presents elevated systematic risk. The fund's current holding is substantial relative to its AUM and the stock's S&P 500 weight, suggesting potential for rebalancing towards the benchmark. Considering the high beta and the fund's medium turnover constraint, a modest reduction in holding might be expected to align closer with the lower-beta benchmark weight while managing risk exposure.</think>
<answer>
{""holding_log_delta"": -0.04}
</answer>","Given the firm's high beta (1.44) and significant market volatility (prev quarter stock_vol_q_prev = 0.1276), the stock presents elevated systematic risk. The fund's current holding is substantial relative to its AUM and the stock's S&P 500 weight, suggesting potential for rebalancing towards the benchmark. Considering the high beta and the fund's medium turnover constraint, a modest reduction in holding might be expected to align closer with the lower-beta benchmark weight while managing risk exposure.","{""holding_log_delta"": -0.04}"
90,population,4,0.47999952000048,0.26999973000027006,0.24999975000025002,ABT,ABBOTT LABORATORIES,694,NA,2017-04-01 00:00:00,20482,27641.646308,0.1045726744661349,-0.02,0.1245726744661349,-0.1245726744661349,True,1,type_mean,0.0082565895035254,0.0069532062192367,0.2194993243101532,0.0782363733443051,"
<think>Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.4418), the stock appears fundamentally strong but with elevated systematic risk. The fund's current holding is substantial relative to AUM, and the stock's S&P 500 weight suggests it is a significant benchmark component. Considering the high beta and the fund's existing large position, a modest increase in holding might be expected to align with the benchmark while managing concentration risk.</think>
<answer>
{""holding_log_delta"": -0.02}
</answer>","Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.4418), the stock appears fundamentally strong but with elevated systematic risk. The fund's current holding is substantial relative to AUM, and the stock's S&P 500 weight suggests it is a significant benchmark component. Considering the high beta and the fund's existing large position, a modest increase in holding might be expected to align with the benchmark while managing concentration risk.","{""holding_log_delta"": -0.02}"
90,population,5,0.47999952000048,0.26999973000027006,0.24999975000025002,ABT,ABBOTT LABORATORIES,694,NA,2017-04-01 00:00:00,20482,27641.646308,0.1045726744661349,-0.02,0.1245726744661349,-0.1245726744661349,True,1,type_mean,0.0082565895035254,0.0069532062192367,0.2194993243101532,0.0782363733443051,"
<think>Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.4418), the stock appears fundamentally strong but with elevated systematic risk. The fund's current holding is substantial relative to AUM, and the stock's S&P 500 weight suggests it is a significant benchmark component. Considering the high beta and the fund's existing large position, a modest increase in holding might be expected to align with the benchmark while managing concentration risk.</think>
<answer>
{""holding_log_delta"": -0.02}
</answer>","Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.4418), the stock appears fundamentally strong but with elevated systematic risk. The fund's current holding is substantial relative to AUM, and the stock's S&P 500 weight suggests it is a significant benchmark component. Considering the high beta and the fund's existing large position, a modest increase in holding might be expected to align with the benchmark while managing concentration risk.","{""holding_log_delta"": -0.02}"
90,population,6,0.47999952000048,0.26999973000027006,0.24999975000025002,ABT,ABBOTT LABORATORIES,694,NA,2017-04-01 00:00:00,20482,27641.646308,0.1045726744661349,-0.02,0.1245726744661349,-0.1245726744661349,True,1,type_mean,0.0082565895035254,0.0069532062192367,0.2194993243101532,0.0782363733443051,"
<think>Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.4418), the stock appears fundamentally strong but with elevated systematic risk. The fund's current holding is substantial relative to AUM, and the stock's S&P 500 weight suggests it is a significant benchmark component. Considering the high beta and the fund's existing large position, a modest increase in holding might be expected to align with the benchmark while managing concentration risk.</think>
<answer>
{""holding_log_delta"": -0.02}
</answer>","Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.4418), the stock appears fundamentally strong but with elevated systematic risk. The fund's current holding is substantial relative to AUM, and the stock's S&P 500 weight suggests it is a significant benchmark component. Considering the high beta and the fund's existing large position, a modest increase in holding might be expected to align with the benchmark while managing concentration risk.","{""holding_log_delta"": -0.02}"
90,population,7,0.48999951000049,0.25999974000026005,0.24999975000025002,ABT,ABBOTT LABORATORIES,694,NA,2017-04-01 00:00:00,20482,27641.646308,0.1045726744661349,-0.04,0.1445726744661349,-0.1445726744661349,True,1,type_mean,0.0082565895035254,0.0069532062192367,0.2194993243101532,0.0782363733443051,"
<think>Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.4418), the stock appears fundamentally strong but with elevated systematic risk. The fund's current holding is relatively small compared to AUM, and the stock's low S&P 500 weight suggests limited benchmark pressure. Considering the high beta and the fund's low turnover constraint, a modest increase in holding might be expected to align with the positive fundamentals while managing risk exposure.</think>
<answer>
{""holding_log_delta"": -0.04}
</answer>","Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.4418), the stock appears fundamentally strong but with elevated systematic risk. The fund's current holding is relatively small compared to AUM, and the stock's low S&P 500 weight suggests limited benchmark pressure. Considering the high beta and the fund's low turnover constraint, a modest increase in holding might be expected to align with the positive fundamentals while managing risk exposure.","{""holding_log_delta"": -0.04}"
90,population,8,0.5288423873511655,0.24273464515246254,0.22842196749637184,ABT,ABBOTT LABORATORIES,694,NA,2017-04-01 00:00:00,20482,27641.646308,0.1045726744661349,-0.04,0.1445726744661349,-0.1445726744661349,True,1,type_mean,0.0082565895035254,0.0069532062192367,0.2194993243101532,0.0782363733443051,"
<think>Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.4418), the stock appears fundamentally strong but with elevated systematic risk. The fund's current holding is substantial relative to AUM, and the stock's S&P 500 weight is modest, suggesting the position may be overweight compared to benchmark. Considering the high beta and the fund's medium turnover constraint, a reduction in holding might be expected to manage risk exposure, though the positive fundamentals could support maintaining or slightly increasing the position.</think>
<answer>
{""holding_log_delta"": -0.04}
</answer>","Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.4418), the stock appears fundamentally strong but with elevated systematic risk. The fund's current holding is substantial relative to AUM, and the stock's S&P 500 weight is modest, suggesting the position may be overweight compared to benchmark. Considering the high beta and the fund's medium turnover constraint, a reduction in holding might be expected to manage risk exposure, though the positive fundamentals could support maintaining or slightly increasing the position.","{""holding_log_delta"": -0.04}"
90,population,9,0.5088423873511654,0.26273464515246275,0.22842196749637186,ABT,ABBOTT LABORATORIES,694,NA,2017-04-01 00:00:00,20482,27641.646308,0.1045726744661349,-0.02,0.1245726744661349,-0.1245726744661349,True,1,type_mean,0.0082565895035254,0.0069532062192367,0.2194993243101532,0.0782363733443051,"
<think>Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.4418), the stock appears fundamentally strong but with elevated systematic risk. The fund's current holding is substantial relative to AUM, and the stock's S&P 500 weight is modest, suggesting the position may be a significant active allocation. Considering the high beta and the fund's medium turnover constraint, a modest increase in holding could be expected to align with the positive fundamentals while managing risk exposure.</think>
<answer>
{""holding_log_delta"": -0.02}
</answer>","Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.4418), the stock appears fundamentally strong but with elevated systematic risk. The fund's current holding is substantial relative to AUM, and the stock's S&P 500 weight is modest, suggesting the position may be a significant active allocation. Considering the high beta and the fund's medium turnover constraint, a modest increase in holding could be expected to align with the positive fundamentals while managing risk exposure.","{""holding_log_delta"": -0.02}"
90,population,10,0.501999498000502,0.26999973000027006,0.22799977200022803,ABT,ABBOTT LABORATORIES,694,NA,2017-04-01 00:00:00,20482,27641.646308,0.1045726744661349,-0.04,0.1445726744661349,-0.1445726744661349,True,1,type_mean,0.0082565895035254,0.0069532062192367,0.2194993243101532,0.0782363733443051,"
<think>Given the firm's high profitability (profit=0.228) and growth (Gat=0.244), alongside a beta above 1 indicating higher systematic risk than the market, the stock appears fundamentally strong but with elevated volatility. The fund's current holding is relatively small compared to its AUM and the stock's S&P 500 weight, suggesting potential for increased allocation to align with benchmark exposure. However, the high beta and recent stock volatility may temper the magnitude of any increase, leading to a modest positive adjustment.</think>
<answer>
{""holding_log_delta"": -0.04}
</answer>","Given the firm's high profitability (profit=0.228) and growth (Gat=0.244), alongside a beta above 1 indicating higher systematic risk than the market, the stock appears fundamentally strong but with elevated volatility. The fund's current holding is relatively small compared to its AUM and the stock's S&P 500 weight, suggesting potential for increased allocation to align with benchmark exposure. However, the high beta and recent stock volatility may temper the magnitude of any increase, leading to a modest positive adjustment.","{""holding_log_delta"": -0.04}"
90,population,11,0.4199996850001313,0.27999979000008757,0.2999995250005313,ABT,ABBOTT LABORATORIES,694,NA,2017-04-01 00:00:00,20482,27641.646308,0.1045726744661349,-0.02,0.1245726744661349,-0.1245726744661349,True,1,type_mean,0.0082565895035254,0.0069532062192367,0.2194993243101532,0.0782363733443051,"
<think>Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.442) indicating higher systematic risk, the stock appears attractive for growth but carries elevated volatility. The fund's current holding is substantial relative to AUM, and the stock's S&P 500 weight suggests it is a significant benchmark component. Considering the high beta and the fund's existing large position, a modest increase in holding might be expected to align with the benchmark while managing concentration risk.</think>
<answer>
{""holding_log_delta"": -0.02}
</answer>","Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.442) indicating higher systematic risk, the stock appears attractive for growth but carries elevated volatility. The fund's current holding is substantial relative to AUM, and the stock's S&P 500 weight suggests it is a significant benchmark component. Considering the high beta and the fund's existing large position, a modest increase in holding might be expected to align with the benchmark while managing concentration risk.","{""holding_log_delta"": -0.02}"
